title: Influence of HLA compatibility on success with living-related pediatric liver transplantation.
abstract: It is not clear how HLA compatibility influences acute rejection and postoperative complications in cadaveric liver transplantation. Even less is known about this factor in pediatric living-related liver transplantation (LRLT). This research assessed HLA compatibility relative to rejection rates and complications in pediatric LRLT. The study retrospectively investigated data from 14 pediatric LRLTs in which the donor and recipient HLA genotypes were determined preoperatively. Three recipients (21.4%) developed biliary complications (two biliary leakage, one bile duct stenosis). Three others (21.4%) developed vascular complications (two hepatic artery thrombosis, one hepatic artery stenosis). Eight recipients (57.1%) were diagnosed with acute rejection. The incidence of acute rejection was not correlated with the number of HLA mismatches (P > .05), or with the number of HLA class I mismatches (P > .05); however, it was negatively correlated with number of HLA class II mismatches (P = .02). Arterial and biliary complications were not correlated with any of these categories of HLA compatibility. In conclusion, the data from this small group of patients provided no evidence that closeness of donor-recipient HLA matching influences outcome in pediatric LRLT.
authors.affiliation: Baskent University Faculty of Medicine, Department of General Surgery, Transplantation Division, Ankara, Turkey.
authors.forename: O
authors.initials: O
authors.lastname: Başaran
authors.forename: F
authors.initials: F
authors.lastname: Ozcay
authors.forename: H
authors.initials: H
authors.lastname: Karakayali
authors.forename: M
authors.initials: M
authors.lastname: Turan
authors.forename: A
authors.initials: A
authors.lastname: Dalgiç
authors.forename: M
authors.initials: M
authors.lastname: Haberal
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D005838:Genotype; D006084:Graft Rejection / Q000517:prevention & control; D006680:HLA Antigens / Q000235:genetics / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D016031:Liver Transplantation / Q000276:immunology*; D019520:Living Donors / Q000145:classification*; D008297:Male; D009679:Nuclear Family; D016896:Treatment Outcome
chemical_list: D006680:HLA Antigens